Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leverger

Showing results (161-170 of 434) with videos related to

Pageof 44
Sort By:
BMC Cancer|June 30, 2006
Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg) in children with relapsed/refractory myeloid leukemiaBenoit Brethon, Anne Auvrignon, Claire Galambrun, et al.
Haematology and Blood Transfusion|January 1, 1990
Treatment of acute lymphoblastic leukemia: protocol Fralle 83-85G Schaison, D Olive, G Leverger, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|October 15, 2010
[Is there a risk of steroid-induced adrenal deficit after induction treatment of acute lymphoblastic leukemia?]V Bélien-Pallet, S Cabrol, S Fasola, et al.
Bulletin Du Cancer|January 1, 1988
[Hodgkin's disease in children. Current therapeutic strategies]O Oberlin, J L Habrand, G Schaison, et al.
British Journal of Haematology|April 19, 2022
Single-dose (4.5 mg/m<sup>2</sup> ) gemtuzumab ozogamicin in combination with fludarabine, cytarabine and anthracycline as reinduction therapy in relapsed or refractory paediatric acute myeloid leukaemiaChloé Dhunputh, Marion Strullu, Arnaud Petit, et al.
Journal of Clinical Microbiology|May 1, 1996
Nosocomial CDC group IV c-2 bacteremia: epidemiological investigation by randomly amplified polymorphic DNA analysisD Moissenet, M D Tabone, J P Girardet, et al.
Pediatric Pulmonology|December 1, 1994
Cytotoxic drug-induced pulmonary disease in infants and childrenB Fauroux, A Meyer-Milsztain, L Boccon-Gibod, et al.
Pediatric Blood & Cancer|January 31, 2004
Carboplatin-epirubicin regimen for the treatment of hepatoblastomaP Blouin, Laurence Brugières, M D Tabone, et al.
Archives Francaises De Pediatrie|February 1, 1992
[Isolated Candida albicans meningitis after treatment of B lymphoma]M Damay, M C Chevalier, F Gouraud, et al.
European Journal of Haematology|July 1, 1987
Plasma lipids in juvenile chronic granulocytic leukaemiaE Turpin, G Leverger, D Erlich, et al.
Pageof 44

Showing results (161-170 of 434) with videos related to

Sort By:
Pageof 44
BMC Cancer|June 30, 2006
Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg) in children with relapsed/refractory myeloid leukemiaBenoit Brethon, Anne Auvrignon, Claire Galambrun, et al.
Haematology and Blood Transfusion|January 1, 1990
Treatment of acute lymphoblastic leukemia: protocol Fralle 83-85G Schaison, D Olive, G Leverger, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|October 15, 2010
[Is there a risk of steroid-induced adrenal deficit after induction treatment of acute lymphoblastic leukemia?]V Bélien-Pallet, S Cabrol, S Fasola, et al.
Bulletin Du Cancer|January 1, 1988
[Hodgkin's disease in children. Current therapeutic strategies]O Oberlin, J L Habrand, G Schaison, et al.
British Journal of Haematology|April 19, 2022
Single-dose (4.5 mg/m<sup>2</sup> ) gemtuzumab ozogamicin in combination with fludarabine, cytarabine and anthracycline as reinduction therapy in relapsed or refractory paediatric acute myeloid leukaemiaChloé Dhunputh, Marion Strullu, Arnaud Petit, et al.
Journal of Clinical Microbiology|May 1, 1996
Nosocomial CDC group IV c-2 bacteremia: epidemiological investigation by randomly amplified polymorphic DNA analysisD Moissenet, M D Tabone, J P Girardet, et al.
Pediatric Pulmonology|December 1, 1994
Cytotoxic drug-induced pulmonary disease in infants and childrenB Fauroux, A Meyer-Milsztain, L Boccon-Gibod, et al.
Pediatric Blood & Cancer|January 31, 2004
Carboplatin-epirubicin regimen for the treatment of hepatoblastomaP Blouin, Laurence Brugières, M D Tabone, et al.
Archives Francaises De Pediatrie|February 1, 1992
[Isolated Candida albicans meningitis after treatment of B lymphoma]M Damay, M C Chevalier, F Gouraud, et al.
European Journal of Haematology|July 1, 1987
Plasma lipids in juvenile chronic granulocytic leukaemiaE Turpin, G Leverger, D Erlich, et al.
Pageof 44